Evaluation of urine biomarkers of kidney injury in polycystic kidney disease

Chirag Parikh, Neera K. Dahl, Arlene B. Chapman, James E. Bost, Charles L. Edelstein, Diane M. Comer, Raoul Zeltner, Xin Tian, Jared J. Grantham, Stefan Somlo

Research output: Contribution to journalArticle

Abstract

Progressive disruption of renal tubular integrity in the setting of increased cellular proliferation and apoptosis is a feature of autosomal dominant polycystic kidney disease (ADPKD). Here we evaluated the effect of these processes on the expression of Lcn2 (NGAL) and interleukin (IL)-18, markers of tubular injury, in rodent models and in the cyst fluid and urine of patients with ADPKD. Two mouse models where Pkd2 was inactivated, which resulted in early- or adult-onset cysts, were used to evaluate NGAL levels. Further, the Han:SPRD rat model of polycystic disease was used to study IL-18 levels. In four annual serial urine samples collected from 107 patients with ADPKD in the Consortium for Radiologic Imaging for the Study of Polycystic Kidney Disease (CRISP) study, NGAL and IL-18 excretion rates were determined in conjunction with measures of total kidney volume and estimated glomerular filtration rate (eGFR) by the Modification of Diet in Renal Disease equation. Kidneys from affected mice and rats showed prominent expression of NGAL and IL-18/IL-18R, respectively, in epithelial cells lining kidney cysts. In human ADPKD cyst fluid, both NGAL and IL-18 were elevated. In CRISP patients, the mean percentage increase in total kidney volume was 5.4/year and the mean decline in eGFR 2.4 ml/min/year. The trend of increased mean urine NGAL and IL-18 over 3 years was statistically significant; however, there was no association between tertiles of IL-18 or quartiles of NGAL and change in total kidney volume or eGFR over this period. Thus, urinary NGAL and IL-18 excretion is mildly and stably elevated in ADPKD, but does not correlate with changes in total kidney volume or kidney function. This may be due, in part, to the lack of communication between individual cysts and the urinary collecting system in this disorder.

Original languageEnglish (US)
Pages (from-to)784-790
Number of pages7
JournalKidney International
Volume81
Issue number8
DOIs
StatePublished - Apr 2 2012

Fingerprint

Polycystic Kidney Diseases
Interleukin-18
Biomarkers
Autosomal Dominant Polycystic Kidney
Urine
Kidney
Wounds and Injuries
Glomerular Filtration Rate
Cyst Fluid
Cysts
Diet Therapy
Interleukins
Rodentia
Epithelial Cells
Communication
Cell Proliferation
Apoptosis

Keywords

  • biomarker
  • IL-18
  • NGAL surrogate

ASJC Scopus subject areas

  • Nephrology

Cite this

Parikh, C., Dahl, N. K., Chapman, A. B., Bost, J. E., Edelstein, C. L., Comer, D. M., ... Somlo, S. (2012). Evaluation of urine biomarkers of kidney injury in polycystic kidney disease. Kidney International, 81(8), 784-790. https://doi.org/10.1038/ki.2011.465

Evaluation of urine biomarkers of kidney injury in polycystic kidney disease. / Parikh, Chirag; Dahl, Neera K.; Chapman, Arlene B.; Bost, James E.; Edelstein, Charles L.; Comer, Diane M.; Zeltner, Raoul; Tian, Xin; Grantham, Jared J.; Somlo, Stefan.

In: Kidney International, Vol. 81, No. 8, 02.04.2012, p. 784-790.

Research output: Contribution to journalArticle

Parikh, C, Dahl, NK, Chapman, AB, Bost, JE, Edelstein, CL, Comer, DM, Zeltner, R, Tian, X, Grantham, JJ & Somlo, S 2012, 'Evaluation of urine biomarkers of kidney injury in polycystic kidney disease', Kidney International, vol. 81, no. 8, pp. 784-790. https://doi.org/10.1038/ki.2011.465
Parikh, Chirag ; Dahl, Neera K. ; Chapman, Arlene B. ; Bost, James E. ; Edelstein, Charles L. ; Comer, Diane M. ; Zeltner, Raoul ; Tian, Xin ; Grantham, Jared J. ; Somlo, Stefan. / Evaluation of urine biomarkers of kidney injury in polycystic kidney disease. In: Kidney International. 2012 ; Vol. 81, No. 8. pp. 784-790.
@article{aaf2baa607df4c77ad707597d1647a13,
title = "Evaluation of urine biomarkers of kidney injury in polycystic kidney disease",
abstract = "Progressive disruption of renal tubular integrity in the setting of increased cellular proliferation and apoptosis is a feature of autosomal dominant polycystic kidney disease (ADPKD). Here we evaluated the effect of these processes on the expression of Lcn2 (NGAL) and interleukin (IL)-18, markers of tubular injury, in rodent models and in the cyst fluid and urine of patients with ADPKD. Two mouse models where Pkd2 was inactivated, which resulted in early- or adult-onset cysts, were used to evaluate NGAL levels. Further, the Han:SPRD rat model of polycystic disease was used to study IL-18 levels. In four annual serial urine samples collected from 107 patients with ADPKD in the Consortium for Radiologic Imaging for the Study of Polycystic Kidney Disease (CRISP) study, NGAL and IL-18 excretion rates were determined in conjunction with measures of total kidney volume and estimated glomerular filtration rate (eGFR) by the Modification of Diet in Renal Disease equation. Kidneys from affected mice and rats showed prominent expression of NGAL and IL-18/IL-18R, respectively, in epithelial cells lining kidney cysts. In human ADPKD cyst fluid, both NGAL and IL-18 were elevated. In CRISP patients, the mean percentage increase in total kidney volume was 5.4/year and the mean decline in eGFR 2.4 ml/min/year. The trend of increased mean urine NGAL and IL-18 over 3 years was statistically significant; however, there was no association between tertiles of IL-18 or quartiles of NGAL and change in total kidney volume or eGFR over this period. Thus, urinary NGAL and IL-18 excretion is mildly and stably elevated in ADPKD, but does not correlate with changes in total kidney volume or kidney function. This may be due, in part, to the lack of communication between individual cysts and the urinary collecting system in this disorder.",
keywords = "biomarker, IL-18, NGAL surrogate",
author = "Chirag Parikh and Dahl, {Neera K.} and Chapman, {Arlene B.} and Bost, {James E.} and Edelstein, {Charles L.} and Comer, {Diane M.} and Raoul Zeltner and Xin Tian and Grantham, {Jared J.} and Stefan Somlo",
year = "2012",
month = "4",
day = "2",
doi = "10.1038/ki.2011.465",
language = "English (US)",
volume = "81",
pages = "784--790",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - Evaluation of urine biomarkers of kidney injury in polycystic kidney disease

AU - Parikh, Chirag

AU - Dahl, Neera K.

AU - Chapman, Arlene B.

AU - Bost, James E.

AU - Edelstein, Charles L.

AU - Comer, Diane M.

AU - Zeltner, Raoul

AU - Tian, Xin

AU - Grantham, Jared J.

AU - Somlo, Stefan

PY - 2012/4/2

Y1 - 2012/4/2

N2 - Progressive disruption of renal tubular integrity in the setting of increased cellular proliferation and apoptosis is a feature of autosomal dominant polycystic kidney disease (ADPKD). Here we evaluated the effect of these processes on the expression of Lcn2 (NGAL) and interleukin (IL)-18, markers of tubular injury, in rodent models and in the cyst fluid and urine of patients with ADPKD. Two mouse models where Pkd2 was inactivated, which resulted in early- or adult-onset cysts, were used to evaluate NGAL levels. Further, the Han:SPRD rat model of polycystic disease was used to study IL-18 levels. In four annual serial urine samples collected from 107 patients with ADPKD in the Consortium for Radiologic Imaging for the Study of Polycystic Kidney Disease (CRISP) study, NGAL and IL-18 excretion rates were determined in conjunction with measures of total kidney volume and estimated glomerular filtration rate (eGFR) by the Modification of Diet in Renal Disease equation. Kidneys from affected mice and rats showed prominent expression of NGAL and IL-18/IL-18R, respectively, in epithelial cells lining kidney cysts. In human ADPKD cyst fluid, both NGAL and IL-18 were elevated. In CRISP patients, the mean percentage increase in total kidney volume was 5.4/year and the mean decline in eGFR 2.4 ml/min/year. The trend of increased mean urine NGAL and IL-18 over 3 years was statistically significant; however, there was no association between tertiles of IL-18 or quartiles of NGAL and change in total kidney volume or eGFR over this period. Thus, urinary NGAL and IL-18 excretion is mildly and stably elevated in ADPKD, but does not correlate with changes in total kidney volume or kidney function. This may be due, in part, to the lack of communication between individual cysts and the urinary collecting system in this disorder.

AB - Progressive disruption of renal tubular integrity in the setting of increased cellular proliferation and apoptosis is a feature of autosomal dominant polycystic kidney disease (ADPKD). Here we evaluated the effect of these processes on the expression of Lcn2 (NGAL) and interleukin (IL)-18, markers of tubular injury, in rodent models and in the cyst fluid and urine of patients with ADPKD. Two mouse models where Pkd2 was inactivated, which resulted in early- or adult-onset cysts, were used to evaluate NGAL levels. Further, the Han:SPRD rat model of polycystic disease was used to study IL-18 levels. In four annual serial urine samples collected from 107 patients with ADPKD in the Consortium for Radiologic Imaging for the Study of Polycystic Kidney Disease (CRISP) study, NGAL and IL-18 excretion rates were determined in conjunction with measures of total kidney volume and estimated glomerular filtration rate (eGFR) by the Modification of Diet in Renal Disease equation. Kidneys from affected mice and rats showed prominent expression of NGAL and IL-18/IL-18R, respectively, in epithelial cells lining kidney cysts. In human ADPKD cyst fluid, both NGAL and IL-18 were elevated. In CRISP patients, the mean percentage increase in total kidney volume was 5.4/year and the mean decline in eGFR 2.4 ml/min/year. The trend of increased mean urine NGAL and IL-18 over 3 years was statistically significant; however, there was no association between tertiles of IL-18 or quartiles of NGAL and change in total kidney volume or eGFR over this period. Thus, urinary NGAL and IL-18 excretion is mildly and stably elevated in ADPKD, but does not correlate with changes in total kidney volume or kidney function. This may be due, in part, to the lack of communication between individual cysts and the urinary collecting system in this disorder.

KW - biomarker

KW - IL-18

KW - NGAL surrogate

UR - http://www.scopus.com/inward/record.url?scp=84859420974&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859420974&partnerID=8YFLogxK

U2 - 10.1038/ki.2011.465

DO - 10.1038/ki.2011.465

M3 - Article

C2 - 22258321

AN - SCOPUS:84859420974

VL - 81

SP - 784

EP - 790

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 8

ER -